`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`PFIZER, INC. and
`SAMSUNG BIOEPIS CO., LTD.,1
`Petitioner,
`
`v.
`
`GENENTECH, INC.,
`Patent Owner,
`____________
`
`IPR2017-01488
`Patent No. 6,407,213
`____________
`
`
`PETITIONER PFIZER’S UPDATED MANDATORY NOTICES
`
`
`1 Samsung Bioepis Co., Ltd.’s IPR2017-02139 has been joined with this
`
`proceeding. (IPR2017-02139, Paper 42.)
`
`
`
`
`
`IPR2017-01488
`Petitioner Pfizer’s Updated Mandatory Notices
`
`
`In accordance with 37 C.F.R. §§ 42.8(a)(3) and (b)(3), Petitioner Pfizer
`
`hereby submits the following updated mandatory notices:
`
`A.
`
`37 C.F.R. § 42.8(b)(2): Related Matters
`
`Petitioner concurrently filed an IPR petition for claims of U.S. Patent No.
`
`6,407,213 (IPR2017-01488).
`
`The ’213 patent is the subject of two earlier IPR proceedings filed by third-
`
`party Mylan Pharmaceuticals Inc.: IPR2016–01693 and IPR2016–01694. These
`
`proceedings were terminated by the Board on March 10, 2017 after the parties filed
`
`a Joint Motion to Terminate. Paper No. 24, IPR2016–01693; Paper No. 23,
`
`IPR2016–01694 (March 10, 2017).
`
`The ’213 patent is also the subject of IPR2017-01373, IPR2017-01374,
`
`IPR2017-02031, IPR2017-02032, IPR2017-02139, and IPR2017-02140. Petitioner
`
`is not a party to those proceedings.
`
`The ’213 patent is also at issue in Amgen Inc v. Genentech, Inc. et al., No. 2-
`
`17-cv-07349 (C.D. Cal.); Genentech, Inc. et al. v. Amgen Inc., No. 1-17-cv-01407
`
`(D. Del.); Genentech, Inc. et al. v. Amgen Inc., No. 1-17-cv-01471 (D. Del.);
`
`Celltrion, Inc. et al. v. Genentech, Inc. et al., No. 3-18-cv-00274 (N.D. Cal.);
`
`Genentech, Inc. et al. v. Celltrion, Inc. et al., No. 1-18-cv-00095 (D. Del.);
`
`Genentech, Inc. et al. v. Amgen, Inc., No. 1-18-cv-00924 (D. Del.); and Genentech,
`
`1
`
`
`
`
`IPR2017-01488
`Petitioner Pfizer’s Updated Mandatory Notices
`
`Inc. et al. v. Celltrion, Inc. et al., No. 1-18-cv-01025(D. Del.). Petitioner is not a
`
`party to these proceedings.
`
`Patent Owner has asserted the ’213 patent against Petitioner in Genentech,
`
`Inc. v. Pfizer, Inc., No. 1-17-cv-01672 (D. Del.), filed November 17, 2017.
`
`Petitioner is not aware of any other judicial or administrative matters that
`
`would affect, or be affected by, a decision in the proceeding.
`
`B.
`
`37 C.F.R. § 42.8(b)(3): Lead and Back-Up Counsel
`
`Lead Counsel
`Amanda Hollis (Reg. No. 55,629)
`amanda.hollis@kirkland.com
`
`Postal and Hand-Delivery Address:
`
`KIRKLAND & ELLIS LLP
`300 North LaSalle
`Chicago, IL 60654
`Telephone: (312) 862-2011
`Facsimile:
`(312) 862-2200
`
`Back-up Counsel
`Benjamin A. Lasky (pro hac vice )
`benjamin.lasky@kirkland.com
`
`Stefan Miller, Ph.D. (Reg. No. 57,623)
`stefan.miller@kirkland.com
`
`Sarah K. Tsou (pro hac vice)
`sarah.tsou@kirkland.com
`
`Mark C. McLennan (pro hac vice)
`mark.mclennan@kirkland.com
`
`Christopher J. Citro (pro hac vice)
`christopher.citro@kirkland.com
`
`Micah Rappazzo (Reg. No. 75,085)
`micah.rappazzo@kirkland.com
`
`Postal and Hand-Delivery Address:
`
`KIRKLAND & ELLIS LLP
`601 Lexington Avenue
`New York, NY 10022
`Telephone: (212) 446-4800
`2
`
`
`
`
`IPR2017-01488
`Petitioner Pfizer’s Updated Mandatory Notices
`
`Lead Counsel
`
`
`
`
`Date: July 12, 2018
`
`
`
`
`
`Back-up Counsel
`Facsimile:
`(212) 446-4900
`
`Sharick Naqi (pro hac vice pending)
`sharick.naqi@kirkland.com
`
`Postal and Hand-Delivery Address:
`
`KIRKLAND & ELLIS LLP
`300 North LaSalle
`Chicago, IL 60654
`Telephone: (312) 862-2011
`Facsimile:
`(312) 862-2200
`
`Karen Younkins (Reg. No. 67,554)
`(request for withdrawal pending)
`karen.younkins@kirkland.com
`
`Postal and Hand-Delivery Address:
`
`KIRKLAND & ELLIS LLP
`333 South Hope Street
`Los Angeles, CA 90071
`Telephone: (213) 680-8140
`Facsimile:
`(213) 680-8500
`
`
`Respectfully submitted,
`
` /Amanda Hollis/
`Amanda Hollis (Reg. No. 55,629)
`Attorney For Petitioner Pfizer, Inc.
`
`3
`
`
`
`
`IPR2017-01488
`Petitioner Pfizer’s Updated Mandatory Notices
`
`
`CERTIFICATE OF SERVICE
`The undersigned hereby certifies that a copy of the foregoing Updated Notices
`
`was served on July 12, 2018, via electronic service on lead and back-up counsel:
`
`For Genentech, Inc.
`david.cavanaugh@wilmerhale.com
`lauren.blakely@wilmerhale.com
`robert.gunther@wilmerhale.com
`abrausa@durietangri.com
`ddurie@durietangri.com
`andrew.danford@wilmerhale.com
`kevin.prussia@wilmerhale.com
`lisa.pirozzolo@wilmerhale.com
`
`For Samsung Bioepis Co., Ltd.:
`ddrivas@whitecase.com
`sweingaertner@whitecase.com
`eric.majchrzak@whitecase.com
`athakore@whitecase.com
`
`
`
` /Amanda Hollis/
`Amanda Hollis
`
`4
`
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
